Category Archives: medical devices

One solution to prescription drug overdoses: make Oyxcontin and similar drugs safer

Share In my previous blogs about West Virginia’s shockingly high rate of prescription drug overdoses — the Mountain State has the second highest rate of overdoses in the nation — I focused on “the culture of disability” that created this … Continue reading

Posted in biotech industry, drug marketing, medical devices, opiods, pharmaceutical industry, prescription drug abuse, public health, Uncategorized | Tagged , , , , , , , | 3 Comments

Fast-moving bill in Congress would weaken FDA oversight of new drugs and devices

Share Congress is moving quickly to pass a bill that would authorize higher industry fees for the FDA in exchange for speeding up the approval of some drugs and medical devices and eliminating restrictions on financial conflicts of interest among … Continue reading

Posted in clinical trials, conflicts of interest, drug marketing, FDA, medical devices, pharmaceutical industry, public health | Tagged , , , , , | 1 Comment

Is the FDA violating its own mandate to approve safe drugs?

Share Is the Food and Drug Administration violating its own mandate to approve safe drugs? That was the question that Donald Light, co-author of The Risk for Prescription Drugs and a long-time medical sociologist, posed at a talk yesterday at … Continue reading

Posted in antidepressants, biotech industry, clinical trials, continuing medical education, drug marketing, FDA, health care costs, medical devices, patient care, pharmaceutical industry, scientific misconduct, suicide rates, Uncategorized | Tagged , , , , , , , , , | 2 Comments

Drug and medical device industry launches push to weaken FDA oversight

Share With the Obama administration hobbled by a Republican-led Congress, the pharmaceutical and medical device industry seems to have launched a concerted push to roll back regulatory initiatives designed to protect consumers from unproven or unsafe drugs and medical devices. … Continue reading

Posted in antidepressants, conflicts of interest, FDA, medical devices, suicide rates | Tagged , , , , , | 2 Comments

What’s behind the growing rate of scientific retractions?

Share The retraction of studies in medical and scientific journals has surged in the last decade, according to separate analyses done by the Wall Street Journal and Retraction Watch. In its page-one article today, the Journal noted that while just … Continue reading

Posted in drug marketing, ghostwriting, medical devices, scientific journal retractions, university industry collaboration | 2 Comments

The real reason biotech industry opposes Medicare advisory panel

Share A page-one story in The Boston Globe today spotlights the Massachusetts biotech industry’s effort to block a key piece of President Obama’s health care overhaul: the creation of an independent payment advisory board (IPAB) that would make recommendations on … Continue reading

Posted in biotech industry, conflicts of interest, drug marketing, health care costs, medical devices, pharmaceutical industry | 2 Comments

Is the credibility of Emory neurologist Helen Mayberg in question? You judge

Share A few weeks ago, I blogged about the strange case of Dr. Helen Mayberg, a neurologist at Emory University who has testified in more death penalty cases in recent years than almost any other doctor in the country. I … Continue reading

Posted in antidepressants, conflicts of interest, expert testimony, medical devices, National Institutes of Health | 1 Comment

Helen Mayberg: A case study in why we need greater transparency about conflicts of interest

Share A year ago, the Department of Health and Human Services proposed new rules governing the disclosure and handling of financial conflicts of interest by medical researchers who receive federal funding. The more stringent rules were prompted by Congressional findings … Continue reading

Posted in conflicts of interest, expert testimony, medical devices, National Institutes of Health, patient care | 2 Comments